Is confirmatory genetic testing of all CF screen positives justified?

Volume: 47, Issue: 15, Pages: 135 - 135
Published: Oct 1, 2014
Abstract
Thiopurine compounds are commonly used in the treatment of childhood acute lymphoblastic leukemia, and as immunosuppressants following organ transplantation or for treatment of various autoimmune disorders. Thiopurine S-methyltransferase (TPMT) is required for detoxification, through S-methylation, of 6-thioguanine nucleotides (TGNs), a byproduct of thiopurine metabolism. Single nucleotide polymorphisms (SNPs) in the TPMT gene have been shown to...
Paper Details
Title
Is confirmatory genetic testing of all CF screen positives justified?
Published Date
Oct 1, 2014
Volume
47
Issue
15
Pages
135 - 135
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.